Skip to main content

Rachel Adams Greenup, MD, MPH

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Campus Mail: DUMC DUMC 3513, Durham, NC 27710

Dr. Greenup is an Associate Professor of Surgery and Population Health Sciences at the Duke School of Medicine and Duke Cancer Institute. She is the founder and co-director of the Duke Breast Cancer Outcomes Research Group, and Core Faculty for the Duke Margolis Center for Health Policy.

She earned her undergraduate degrees in Zoology and Psychology at the University of Wisconsin, where she later completed a Masters in Public Health. She attended the Medical College of Wisconsin for Medical School and General Surgery Residency, and went on to complete a Breast Surgical Oncology Fellowship at the Massachusetts General Hospital, Dana Farber Cancer Institute, and Brigham and Women’s Hospital. In 2016, she received the National Institutes of Health Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Award to evaluate how financial costs and burden relate to preference-sensitive decisions for breast cancer surgery. In 2017, she was named the American College of Surgeons & American Society of Breast Surgeons Health Policy Scholar. More broadly, her research focuses on aligning patient-centered care with high quality, lower cost treatment.

Dr. Greenup serves on several national committees, including the Alliance in Clinical Oncology Ethics and Value Committees, the American College of Surgeons Cancer Care Delivery Task Force, the American Society of Breast Surgeons Legislative Committee, and the Editorial Board for the Annals of Surgical Oncology. 

Education and Training

  • Breast Surgical Oncology Fellow, Massachusetts General Hospital, 2011 - 2012
  • Internship/General Surgery Residency, Medical College of Wisconsin, 2004 - 2011
  • M.P.H., University of Wisconsin - Madison, 2009
  • M.D., Medical College of Wisconsin, 2004

Publications

Greenup, R. A., C. N. Rushing, L. J. Fish, B. Campbell, T. Hyslop, J. M. Peppercorn, E. R. Myers, Y. Zafar, and E. S. Hwang. “Breast Cancer Treatment Costs: Surgical Decisions and Preferences for Transparency.” In Annals of Surgical Oncology, 25:S15–S15. SPRINGER, 2018.

Scholars@Duke

Plichta, J. K., S. M. Thomas, R. A. Greenup, O. M. Fayanju, L. H. Rosenberger, N. Tamirisa, T. Hyslop, and E. S. Hwang. “Clinical and Pathologic Stage Discordance is Associated with Breast Cancer Prognosis.” In Annals of Surgical Oncology, 25:S94–S94. SPRINGER, 2018.

Scholars@Duke

Oyekunle, Taofik O., Samantha M. Thomas, Rachel A. Greenup, Terry Hyslop, and Kimberly Blackwell. “Incidence and mortality among breast cancer patients .” In Cancer Research, Vol. 78. AMER ASSOC CANCER RESEARCH, 2018.

Scholars@Duke

Nussbaum, D. P., Z. Sun, B. A. Yerokun, C. N. Rushing, D. Niedzwiecki, R. A. Greenup, and D. G. Blazer. “Measuring the Quality of Gastric Cancer Care in the United.” In Annals of Surgical Oncology, 25:S69–S69. SPRINGER, 2018.

Scholars@Duke

Jakub, James W., Anne Warren Peled, Richard J. Gray, Rachel A. Greenup, John V. Kiluk, Virgilio Sacchini, Sarah A. McLaughlin, et al. “Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.” Jama Surgery 153, no. 2 (February 2018): 123–29. https://doi.org/10.1001/jamasurg.2017.3422.

Full Text

Greenup, Rachel A., Samilia Obeng-Gyasi, Samantha Thomas, K. Houck, Whitney O. Lane, Rachel C. Blitzblau, Terry Hyslop, and E Shelley Hwang. “The Effect of Hospital Volume on Breast Cancer Mortality.” Ann Surg 267, no. 2 (February 2018): 375–81. https://doi.org/10.1097/SLA.0000000000002095.

Full Text

Thomas, S. M., O. M. Fayanju, J. K. Plichta, L. H. Rosenberger, J. Force, T. Hyslop, E. S. Hwang, and R. A. Greenup. “Treatment Patterns and Outcomes for Breast Cancer with Isolated Supraclavicular Metastases.” In Annals of Surgical Oncology, 25:S26–S26. SPRINGER, 2018.

Scholars@Duke

Shammas, Ronnie L., Eugenia H. Cho, Adam D. Glener, Luke P. Poveromo, Lily R. Mundy, Rachel A. Greenup, Kimberly L. Blackwell, and Scott T. Hollenbeck. “Association Between Targeted HER-2 Therapy and Breast Reconstruction Outcomes: A Propensity Score-Matched Analysis.” J Am Coll Surg 225, no. 6 (December 2017): 731-739.e1. https://doi.org/10.1016/j.jamcollsurg.2017.08.023.

Full Text

Cho, Eugenia H., Ronnie L. Shammas, Adam D. Glener, Rachel A. Greenup, E Shelley Hwang, and Scott T. Hollenbeck. “The Impact of Autologous Breast Reconstruction on Body Mass Index Patterns in Breast Cancer Patients: A Propensity-Matched Analysis.” Plast Reconstr Surg 140, no. 6 (December 2017): 1121–31. https://doi.org/10.1097/PRS.0000000000003841.

Full Text

Ong, Cecilia T., Samantha M. Thomas, Rachel C. Blitzblau, Oluwadamilola M. Fayanju, Tristen S. Park, Jennifer K. Plichta, Laura H. Rosenberger, Terry Hyslop, E. Shelley Hwang, and Rachel A. Greenup. “Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.” Ann Surg Oncol 24, no. 12 (November 2017): 3559–66. https://doi.org/10.1245/s10434-017-6075-0.

Full Text

Pages